US Stock MarketDetailed Quotes

TNDM Tandem Diabetes Care

Watchlist
  • 17.980
  • -0.180-0.99%
Trading Mar 11 12:27 ET
1.20BMarket Cap-12.23P/E (TTM)

Tandem Diabetes Care Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
25.74%940.2M
43.62%282.65M
31.43%243.97M
13.27%221.91M
13.16%191.67M
-6.68%747.72M
-10.75%196.8M
-9.25%185.62M
-2.17%195.92M
-3.71%169.38M
Operating revenue
25.74%940.2M
43.62%282.65M
31.43%243.97M
13.27%221.91M
13.16%191.67M
-6.68%747.72M
-10.75%196.8M
-9.25%185.62M
-2.17%195.92M
-3.71%169.38M
Cost of revenue
18.58%450.63M
20.96%125.19M
24.46%119.32M
15.86%109.12M
12.17%97M
-2.11%380.03M
-1.41%103.5M
-4.25%95.87M
-4.20%94.18M
1.96%86.48M
Gross profit
33.15%489.57M
68.77%157.46M
38.88%124.65M
10.87%112.79M
14.19%94.67M
-10.97%367.69M
-19.24%93.3M
-14.05%89.75M
-0.21%101.74M
-8.99%82.91M
Operating expense
-2.03%588.7M
-23.69%158.04M
24.28%150.75M
2.15%143.57M
-35.29%136.35M
18.80%600.92M
55.37%207.11M
-20.16%121.3M
23.08%140.54M
97.99%210.72M
Selling and administrative expenses
10.59%389.82M
23.42%105.84M
25.60%99.64M
-3.45%94.24M
0.33%90.11M
5.01%352.5M
-12.22%85.75M
-5.68%79.33M
21.08%97.61M
22.58%89.81M
Research and development costs
-19.94%198.88M
-56.99%52.2M
21.77%51.11M
14.89%49.33M
-61.75%46.24M
46.00%248.42M
240.81%121.35M
-38.11%41.97M
27.89%42.93M
264.63%120.91M
Operating profit
57.50%-99.13M
99.49%-582K
17.28%-26.09M
20.70%-30.77M
67.39%-41.68M
-151.20%-233.23M
-540.17%-113.81M
33.58%-31.55M
-217.08%-38.81M
-733.34%-127.82M
Net non-operating interest income expense
-18.48%10.58M
-29.31%2.65M
326.35%3.48M
-75.33%1.03M
-19.24%3.42M
8,636.84%12.98M
147.36%3.75M
466.67%816K
688.59%4.18M
484.29%4.23M
Non-operating interest income
-21.28%17.99M
-18.76%4.51M
-5.52%5.34M
-51.18%2.82M
-9.39%5.31M
277.38%22.86M
79.36%5.55M
228.84%5.66M
600.24%5.78M
1,313.25%5.87M
Non-operating interest expense
-31.81%5.51M
-102.69%-46K
-54.93%1.87M
11.71%1.79M
20.47%1.43M
87.32%8.08M
58.57%1.71M
283.86%4.14M
48.89%1.61M
10.11%1.19M
Total other finance cost
5.71%1.91M
----
----
----
4.47%467K
-4.91%1.8M
-81.64%92K
40.96%702K
----
2.05%447K
Other net income (expense)
-3.32M
-2.05M
-1.27M
Earnings from equity interest
---2.05M
----
----
----
----
--0
----
----
----
----
Special income (charges)
---1.27M
--0
--0
--0
---1.27M
--0
--78.75M
--0
--0
--0
-Less:Other special charges
--1.27M
--0
----
----
--1.27M
----
----
----
----
----
Income before tax
58.29%-91.87M
100.05%16K
26.41%-22.61M
14.11%-29.74M
68.01%-39.53M
-137.21%-220.25M
-94.30%-31.31M
35.10%-30.73M
-167.41%-34.63M
-651.79%-123.59M
Income tax
76.28%4.16M
43.50%-739K
-71.46%637K
-6.54%1.07M
1,010.10%3.19M
35.30%2.36M
-401.15%-1.31M
37.69%2.23M
-45.58%1.15M
116.65%287K
Net income
56.86%-96.03M
102.52%755K
29.46%-23.25M
13.87%-30.81M
65.52%-42.72M
-135.33%-222.61M
-89.25%-30M
32.69%-32.96M
-137.61%-35.78M
-741.81%-123.87M
Net income continuous Operations
56.86%-96.03M
102.52%755K
29.46%-23.25M
13.87%-30.81M
65.52%-42.72M
-135.33%-222.61M
-89.25%-30M
32.69%-32.96M
-137.61%-35.78M
-741.81%-123.87M
Minority interest income
Net income attributable to the parent company
56.86%-96.03M
102.52%755K
29.46%-23.25M
13.87%-30.81M
65.52%-42.72M
-135.33%-222.61M
-89.25%-30M
32.69%-32.96M
-137.61%-35.78M
-741.81%-123.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
56.86%-96.03M
102.52%755K
29.46%-23.25M
13.87%-30.81M
65.52%-42.72M
-135.33%-222.61M
-89.25%-30M
32.69%-32.96M
-137.61%-35.78M
-741.81%-123.87M
Basic earnings per share
57.14%-1.47
102.17%0.01
31.37%-0.35
14.55%-0.47
66.15%-0.65
-133.33%-3.43
-84.00%-0.46
32.89%-0.51
-139.13%-0.55
-734.78%-1.92
Diluted earnings per share
57.14%-1.47
102.17%0.01
31.37%-0.35
14.55%-0.47
66.15%-0.65
-133.33%-3.43
-84.00%-0.46
32.89%-0.51
-129.17%-0.55
-734.78%-1.92
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 25.74%940.2M43.62%282.65M31.43%243.97M13.27%221.91M13.16%191.67M-6.68%747.72M-10.75%196.8M-9.25%185.62M-2.17%195.92M-3.71%169.38M
Operating revenue 25.74%940.2M43.62%282.65M31.43%243.97M13.27%221.91M13.16%191.67M-6.68%747.72M-10.75%196.8M-9.25%185.62M-2.17%195.92M-3.71%169.38M
Cost of revenue 18.58%450.63M20.96%125.19M24.46%119.32M15.86%109.12M12.17%97M-2.11%380.03M-1.41%103.5M-4.25%95.87M-4.20%94.18M1.96%86.48M
Gross profit 33.15%489.57M68.77%157.46M38.88%124.65M10.87%112.79M14.19%94.67M-10.97%367.69M-19.24%93.3M-14.05%89.75M-0.21%101.74M-8.99%82.91M
Operating expense -2.03%588.7M-23.69%158.04M24.28%150.75M2.15%143.57M-35.29%136.35M18.80%600.92M55.37%207.11M-20.16%121.3M23.08%140.54M97.99%210.72M
Selling and administrative expenses 10.59%389.82M23.42%105.84M25.60%99.64M-3.45%94.24M0.33%90.11M5.01%352.5M-12.22%85.75M-5.68%79.33M21.08%97.61M22.58%89.81M
Research and development costs -19.94%198.88M-56.99%52.2M21.77%51.11M14.89%49.33M-61.75%46.24M46.00%248.42M240.81%121.35M-38.11%41.97M27.89%42.93M264.63%120.91M
Operating profit 57.50%-99.13M99.49%-582K17.28%-26.09M20.70%-30.77M67.39%-41.68M-151.20%-233.23M-540.17%-113.81M33.58%-31.55M-217.08%-38.81M-733.34%-127.82M
Net non-operating interest income expense -18.48%10.58M-29.31%2.65M326.35%3.48M-75.33%1.03M-19.24%3.42M8,636.84%12.98M147.36%3.75M466.67%816K688.59%4.18M484.29%4.23M
Non-operating interest income -21.28%17.99M-18.76%4.51M-5.52%5.34M-51.18%2.82M-9.39%5.31M277.38%22.86M79.36%5.55M228.84%5.66M600.24%5.78M1,313.25%5.87M
Non-operating interest expense -31.81%5.51M-102.69%-46K-54.93%1.87M11.71%1.79M20.47%1.43M87.32%8.08M58.57%1.71M283.86%4.14M48.89%1.61M10.11%1.19M
Total other finance cost 5.71%1.91M------------4.47%467K-4.91%1.8M-81.64%92K40.96%702K----2.05%447K
Other net income (expense) -3.32M-2.05M-1.27M
Earnings from equity interest ---2.05M------------------0----------------
Special income (charges) ---1.27M--0--0--0---1.27M--0--78.75M--0--0--0
-Less:Other special charges --1.27M--0----------1.27M--------------------
Income before tax 58.29%-91.87M100.05%16K26.41%-22.61M14.11%-29.74M68.01%-39.53M-137.21%-220.25M-94.30%-31.31M35.10%-30.73M-167.41%-34.63M-651.79%-123.59M
Income tax 76.28%4.16M43.50%-739K-71.46%637K-6.54%1.07M1,010.10%3.19M35.30%2.36M-401.15%-1.31M37.69%2.23M-45.58%1.15M116.65%287K
Net income 56.86%-96.03M102.52%755K29.46%-23.25M13.87%-30.81M65.52%-42.72M-135.33%-222.61M-89.25%-30M32.69%-32.96M-137.61%-35.78M-741.81%-123.87M
Net income continuous Operations 56.86%-96.03M102.52%755K29.46%-23.25M13.87%-30.81M65.52%-42.72M-135.33%-222.61M-89.25%-30M32.69%-32.96M-137.61%-35.78M-741.81%-123.87M
Minority interest income
Net income attributable to the parent company 56.86%-96.03M102.52%755K29.46%-23.25M13.87%-30.81M65.52%-42.72M-135.33%-222.61M-89.25%-30M32.69%-32.96M-137.61%-35.78M-741.81%-123.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 56.86%-96.03M102.52%755K29.46%-23.25M13.87%-30.81M65.52%-42.72M-135.33%-222.61M-89.25%-30M32.69%-32.96M-137.61%-35.78M-741.81%-123.87M
Basic earnings per share 57.14%-1.47102.17%0.0131.37%-0.3514.55%-0.4766.15%-0.65-133.33%-3.43-84.00%-0.4632.89%-0.51-139.13%-0.55-734.78%-1.92
Diluted earnings per share 57.14%-1.47102.17%0.0131.37%-0.3514.55%-0.4766.15%-0.65-133.33%-3.43-84.00%-0.4632.89%-0.51-129.17%-0.55-734.78%-1.92
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------